Kalidor, a contract research laboratory, signs two agreements: (1) with Pharmeo, which pays it a fixed fee to carry out a series of trials and receive all of the results; (2) with Biomont, with which it develops a process sharing the costs, risks and future profits. Which agreement(s) is (are) within the scope of IFRS 15 for Kalidor?
Single choiceIntermediatePublished